Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score

Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score

Abstract Aims Transthyretin ‘wild‐type’ amyloid cardiomyopathy (ATTRwt‐CM) is a differential diagnosis of heart failure with preserved ejection fraction (HFpEF). The clinical work‐up for ATTRwt‐CM is challenging. Considering a combination of clinical variables specific for ATTRwt‐CM might aid in ide...

Full description

Bibliographic Details
Main Authors: Guglielmo Gioia, Lore Schrutka, Joanna Jozwiak‐Nozdrzykowska, Karl‐Patrik Kresoja, Hilka Gunold, Karin Klingel, Holger Thiele, Diana Bonderman, Philipp Lurz, Karl‐Philipp Rommel
Format: Article
Language:English
Published: Wiley 2024-08-01
Series:ESC Heart Failure
Subjects:
ATTRwt
AMY score
Cardiac amyloidosis
Endomyocardial biopsy
Heart failure with preserved ejection fraction
Screening
Online Access:https://doi.org/10.1002/ehf2.14786

Internet

https://doi.org/10.1002/ehf2.14786

Similar Items